Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

• Main Authors: F. Cankat Tulunay (Author), Kamila Wendykowska (Author), Inês Teixeira (Author), Catherine Sermet (Author), Ulrich Schwabe (Author), Roberta Joppi (Author), Ott Laius (Author), Marija Kalaba (Author), Kristina Garuolienè (Author), Thomas Burkhardt (Author), Morten Andersen (Author), Iain Bishop (Author), Bjorn Wettermark (Author), William Shrank (Author), Brian Godman (Author), Corinne Zara (Author), Lars L Gustafsson (Author)
• Format: Book
• Published: MDPI AG, 2010-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pharmaceutical expenditures in ambulatory care rose rapidly in Europe in the 1990s and early 2000s. This was typically faster than other components of healthcare spending, leading to reforms to moderate future growth. A number of these centered on generic medicines with measures to lower reimbursed...